Which rapid COVID test is more accurate? a Head-to-Head showdown

NCT ID NCT04403035

Terminated Diagnosis Sponsor: Henry Ford Health System Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study compares two rapid point-of-care tests for COVID-19: the ID NOW and the Accula. The goal is to see which one is more accurate at detecting the virus, by measuring sensitivity, specificity, and predictive values. Adults who need a COVID-19 test or have already tested positive are eligible to participate. The results could help hospitals choose the better test for quick and reliable diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Two rapid diagnostic tests: ID NOW and Accula
What this could lead to: If one test proves more accurate, it could become the preferred choice for quick COVID-19 detection, leading to faster isolation and treatment decisions.
What could go wrong: The trial is small and early, and results may not apply to all settings. Also, rapid tests can sometimes miss infections, so accuracy may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19

Contacts and locations

Locations

Ascension St. John Hospital

Detroit, Michigan, 48236, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.